Revvity, Inc. (RVTY)

Price$98.37

Value ScoreC

Growth ScoreD

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-13.71%

Price vs S&P 500 (4W)-2.59%

VGM Score43.25

Market Capitalization$10.97B

P/E Ratio (Annual)45.50x

Indicated Dividend Yield (Annual)0.27%

All Metrics

P/CF (Annual)18.83x

Book Value / Share (Quarterly)$64.34

P/TBV (Annual)2.25x

Indicated Dividend (Annual)$0.28

Revenue Growth (3Y)-4.82%

Cash Flow / Share (Quarterly)$4.41

Payout Ratio (TTM)13.44%

Price vs S&P 500 (YTD)-6.48%

Gross Margin (TTM)54.32%

Net Profit Margin (TTM)8.26%

EPS (TTM)$2.10

10-Day Avg Trading Volume1.72M

EPS Excl Extra (TTM)$2.10

Revenue Growth (5Y)-5.46%

EPS (Annual)$2.07

Dividend / Share (Annual)$0.28

ROI (Annual)2.30%

Gross Margin (Annual)54.77%

Net Profit Margin (5Y Avg)17.06%

Cash / Share (Quarterly)$7.71

P/E Basic Excl Extra (TTM)45.79x

Revenue Growth QoQ (YoY)6.97%

EPS Growth (5Y)-20.45%

P/E Normalized (Annual)45.50x

ROA (Last FY)1.98%

Revenue Growth TTM (YoY)4.79%

EBITD / Share (TTM)$6.75

ROE (5Y Avg)7.32%

Operating Margin (TTM)12.41%

Cash Flow / Share (Annual)$4.54

P/B Ratio1.53x

P/B Ratio (Quarterly)1.37x

Net Income / Employee (Annual)$21,900

EV / Revenue (TTM)4.59x

Net Interest Coverage (TTM)4.07x

ROA (TTM)1.97%

EPS Growth QoQ (YoY)3.62%

EV / EBITDA (TTM)17.23x

EPS Incl Extra (Annual)$2.07

Current Ratio (Annual)1.68x

Quick Ratio (Quarterly)1.41x

3-Month Avg Trading Volume1.32M

52-Week Price Return8.70%

EV / Free Cash Flow (Annual)26.15x

P/E Incl Extra (TTM)45.79x

Revenue / Employee (TTM)$263,900

Tangible BV / Share (Quarterly)$43.68

P/S Ratio (Annual)3.84x

Asset Turnover (Annual)0.23x

52-Week High$118.30

Operating Margin (5Y Avg)18.26%

EPS Excl Extra (Annual)$2.07

CapEx CAGR (5Y)-1.05%

26-Week Price Return-5.78%

Quick Ratio (Annual)1.40x

13-Week Price Return1.86%

Total Debt / Equity (Annual)0.44x

Current Ratio (Quarterly)1.72x

Enterprise Value$13.32B

Revenue / Share Growth (5Y)-6.21%

Asset Turnover (TTM)0.24x

Book Value / Share Growth (5Y)20.85%

Revenue / Employee (Annual)$259,600

Inventory Turnover (Annual)3.46x

Pretax Margin (Annual)9.39%

Cash / Share (Annual)$8.19

3-Month Return Std Dev43.43%

Gross Margin (5Y Avg)58.05%

Net Income / Employee (TTM)$21,800

EBITDA CAGR (5Y)-9.06%

EBITDA Interim CAGR (5Y)-19.58%

ROE (Last FY)3.33%

Net Interest Coverage (Annual)3.64x

EPS Basic Excl Extra (Annual)$2.07

P/FCF (TTM)22.27x

Receivables Turnover (TTM)4.44x

EV / Free Cash Flow (TTM)27.04x

Total Debt / Equity (Quarterly)0.45x

EPS Incl Extra (TTM)$2.10

Receivables Turnover (Annual)4.15x

ROI (TTM)2.27%

Dividend Growth Rate (5Y)0.08%

P/S Ratio (TTM)3.78x

Pretax Margin (5Y Avg)15.73%

Revenue / Share (Annual)$24.50

Tangible BV / Share (Annual)$43.67

Forward P/E19.01x

Free OCF CAGR (5Y)-8.96%

Price vs S&P 500 (52W)-15.67%

P/E Ratio (TTM)45.79x

EPS Growth TTM (YoY)-10.65%

Year-to-Date Return1.67%

5-Day Price Return-2.14%

EPS Normalized (Annual)$2.07

ROA (5Y Avg)3.92%

Net Profit Margin (Annual)8.45%

Month-to-Date Return-5.91%

Cash Flow / Share (TTM)$5.13

EBITD / Share (Annual)$6.54

EPS Growth (3Y)-22.83%

Operating Margin (Annual)12.49%

LT Debt / Equity (Annual)0.36x

P/CF (TTM)19.25x

ROI (5Y Avg)4.66%

P/E Excl Extra (TTM)45.79x

LT Debt / Equity (Quarterly)0.37x

EPS Basic Excl Extra (TTM)$2.10

P/TBV (Quarterly)2.02x

Payout Ratio (Annual)13.60%

P/B Ratio (Annual)1.52x

Dividend / Share (TTM)$0.28

Inventory Turnover (TTM)3.45x

Pretax Margin (TTM)9.16%

Book Value / Share (Annual)$64.57

Price vs S&P 500 (13W)-6.39%

Net Margin Growth (5Y)-15.17%

Dividend Yield (TTM)0.29%

Beta1.10x

P/FCF (Annual)21.54x

Revenue / Share (TTM)$25.94

ROE (TTM)3.26%

52-Week Low$81.22

vGradeC

gGradeD

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q1 261.06est. 1.04

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

3.73

3.77

3.76

3.75

Industry Peers — Lab Analytical Instruments(24)

Symbol	Value Score	Growth Score	Momentum Score	Price
RVTYRevvity, Inc.	C	D	C	$98.37
AAgilent Technologies Inc.	C	C	B	$135.44
WATWaters Corp	D	C	C	$365.36
ILMNIllumina Inc	D	D	B	$162.32
MTDMettler-Toledo International	D	C	C	$1154.33
BRKRBruker Corporation	D	D	B	$56.39
BIOBio-Rad Laboratories, Inc.Class A	C	F	B	$294.32
BIO.BBio-Rad Laboratories, Inc. Class B	C	F	B	$304.15
AVTRAvantor, Inc.	B	D	C	$9.16
TXG10x Genomics, Inc. Class A Common Stock	D	C	A	$31.04
ALMRAlamar Biosciences, Inc. Common Stock	—	—	A	$20.54

About

Revvity, formed in 2023 through PerkinElmer's rebranding, is a global life sciences and diagnostics company serving biopharma, academic research, and clinical markets. The company operates two segments: Life Sciences, providing reagents and instruments for research applications, and Diagnostics, delivering immunodiagnostics and newborn and reproductive health solutions. With established operations across North America, Europe, and China, Revvity serves customers worldwide in research and clinical diagnostics.